학술논문

A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe.
Document Type
Article
Source
Diabetes & Primary Care; 2020, Vol. 22 Issue 3, p1-21, 21p
Subject
INSULIN therapy
OBESITY risk factors
BEHAVIOR modification
CARDIOVASCULAR diseases risk factors
CHRONIC kidney failure
CORONARY disease
DECISION making
ENZYME inhibitors
HEALTH behavior
HEART failure
HYPOGLYCEMIC agents
TYPE 2 diabetes
PRIMARY health care
RISK assessment
DISEASE management
SULFONYLUREAS
METFORMIN
PATIENT-centered care
THIAZOLIDINEDIONES
PIOGLITAZONE
SODIUM-glucose cotransporters
GLUCAGON-like peptide-1 agonists
GLYCEMIC control
DISEASE complications
DISEASE risk factors
Language
ISSN
14668955
Abstract
Copyright of Diabetes & Primary Care is the property of SB Communications Group, A Schofield Media Company and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Online Access